Publication: REVIEW: Biopsy of Renal Masses: When and Why
Open/View Files
Date
2009
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
E-MED LTD
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Anik Sahni, V. Stuart G. Silverman. 2009. “REVIEW: Biopsy of Renal Masses: When and Why.” Cancer Imaging 9 (1): 44–55. doi:10.1102/1470-7330.2009.0005.
Research Data
Abstract
Percutaneous image-guided biopsy of renal masses is a safe and accurate procedure. Although once reserved for the diagnosis of unresectable renal cell carcinoma, metastases, lymphoma, and infection, today percutaneous image-guided biopsy has an expanded role. There is increasing awareness that a substantial proportion of small, solid renal masses are benign neoplasms. Although imaging can be used to diagnose most of them, some are incorrectly believed to represent renal cell carcinoma and unnecessary surgery may be performed. Based largely on advances in cytological techniques, percutaneous biopsy can be now be used to diagnose benign neoplasms and thus prevent them from being treated unnecessarily. Concurrent advances in percutaneous ablation have also promoted its use. As a result, there are 8 established indications for percutaneous biopsy, and reason to believe that the number of indications will expand further in the future.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service